Haroon A Mann: Focusing on Inequities in Haemophilia Care in Low-Resource Settings at WHC 2026
Haroon A Mann, Consultant Trauma and Orthopaedic Surgeon at Royal Free Hospital London NHS Foundation Trust, shared on LinkedIn:
”Attending the World Haemophilia Congress in Kuala Lumpur this week has reinforced something I’ve seen throughout 20 years in medicine, orthopaedics and trauma surgery.
In well-resourced systems, haemophilia is a manageable condition – safe surgery, reliable factor access, predictable outcomes.
Data and outcomes from my institution in The Royal Free London NHS dates back over 60 years, undertaking safe and effective orthopaedic surgery in haemophilic patients.
In many lower-resource settings, lack of access to basic clotting factor still turns routine surgery into high-risk or impossible care.
In developed healthcare systems, we are fortunate and able to undertake complex orthopaedic procedures with confidence, supported by amazing experts with reliable and timely access to clotting factors.
In contrast, in many developing settings, even basic surgical interventions may be deferred or avoided entirely due to life threatening bleeding risk and lack of resources.
Patients with haemophilia who sustain trauma – whether from road traffic accidents or due to lack of infrastructure , may have limited or no access to clotting factor at all, with catastrophic and often fatal bleeding risk.
The result is not a lack of medical knowledge – but a lack of system capacity.
This too remains an under-recognised dimension of conflict medicine and health security.
The science exists. The inequality is systemic.”
Stay updated with Hemostasis Today.
-
Jun 29, 2026, 03:10Aryabhatta Sadhu: ABO and Rh Incompatibility In Stem Cell Transplantation
-
Jun 29, 2026, 02:41Arun V. J.: ISBT Is Where the Future of Transfusion Medicine Begins
-
Jun 29, 2026, 02:41Manish Raturi: Does Patient Type Matter in Massive Blood Transfusion?
-
Jun 29, 2026, 02:25Hortense Ngegni: From Poster Presentation to Global Connections at ISBT 2026
-
Jun 29, 2026, 01:19Peter Jaworski: Grateful to Win the 2026 Plasma Hero Award at Immune Deficiency Foundation Conference
-
Jun 29, 2026, 01:11Gerrit M. Grosse: Mapping the Landscape of Biomarkers in Post-Stroke Cognitive Impairment
-
Jun 29, 2026, 01:07Katerina Pavenski: Key Insights on Patient Blood Management at ISBT 2026
-
Jun 28, 2026, 19:05Jack Shuang Hou: Novo Nordisk to Present New Haemophilia Data on Investigational Denecimig at ISTH 2026
-
Jun 28, 2026, 19:05Pinar Demirtepe: Not All “Blood Thinners” Are the Same